Day One Biopharmaceuticals (DAWN) Shares Issued: 2022-2025
Historic Shares Issued for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Jun 2025 value amounting to $748,000.
- Day One Biopharmaceuticals' Shares Issued fell 19.14% to $748,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $178.9 million, marking a year-over-year increase of 10.05%. This contributed to the annual value of $178.2 million for FY2024, which is 10.39% up from last year.
- Day One Biopharmaceuticals' Shares Issued amounted to $748,000 in Q2 2025, which was down 99.58% from $177.2 million recorded in Q3 2024.
- Day One Biopharmaceuticals' Shares Issued's 5-year high stood at $177.2 million during Q3 2024, with a 5-year trough of $9,000 in Q3 2023.
- Its 3-year average for Shares Issued is $48.8 million, with a median of $925,000 in 2024.
- The largest annual percentage gain for Day One Biopharmaceuticals' Shares Issued in the last 5 years was 1,968,833.33% (2024), contrasted with its biggest fall of 99.43% (2024).
- Day One Biopharmaceuticals' Shares Issued (Quarterly) stood at $161.6 million in 2022, then remained steady at $9,000 in 2023, then soared by 1,968,833.33% to $177.2 million in 2024, then fell by 19.14% to $748,000 in 2025.
- Its Shares Issued stands at $748,000 for Q2 2025, versus $177.2 million for Q3 2024 and $925,000 for Q2 2024.